Chimerix. has been granted a patent for methods of treating cancer using specific compounds and their analogs, including pharmaceutical compositions containing these compounds. The patent outlines the administration of these compounds to subjects requiring treatment. GlobalData’s report on Chimerix gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Chimerix, Human telomerase RT biomarker was a key innovation area identified from patents. Chimerix's grant share as of June 2024 was 42%. Grant share is based on the ratio of number of grants to total number of patents.
Cancer treatment using specific pharmaceutical compounds
The granted patent US11976068B2 outlines a pharmaceutical composition that includes a specific compound identified by formula (1). This composition is designed for therapeutic applications, although the specific uses and benefits of the compound are not detailed in the claims. The formulation is significant in the context of pharmaceutical development, as it may offer new avenues for treatment or improved efficacy in existing therapies.
Additionally, the patent specifies that the composition may utilize a hydrochloride di-salt form of the compound. The inclusion of a di-salt, particularly in the hydrochloride form, suggests potential advantages in terms of solubility, stability, or bioavailability, which are critical factors in drug formulation. This detail indicates a focus on optimizing the pharmaceutical properties of the compound to enhance its performance in clinical settings.
To know more about GlobalData’s detailed insights on Chimerix, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
